|
pubmed:abstractText |
The purpose of the present study was to determine relationship between disease activity, systemic markers of cartilage degradation, urinary C-terminal cross-linking telopeptides of type II collagen (uCTX-II), and bone degradation, urinary C-terminal cross-linking telopeptides of type I collagen (uCTX-I), structural progression of osteoarthritis (OA) and potential therapeutic efficacy of type II collagen (COLLII) in combination with glucosamine and chondroitin sulfate (GC).
|
|
pubmed:affiliation |
Rheumatology Unit, Magenta Hospital Italy, Via al Donatore di Sangue 50, 20013 Magenta, Milan, Italy. magda.scarpellini@ao-legnano.it
|
